Methodology for guideline development for the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy -: The Seventh ACCP Conference on Antithrombotic and Thrombolytic

被引:25
|
作者
Schünemann, HJ [1 ]
Munger, H [1 ]
Brower, S [1 ]
O'Donnell, M [1 ]
Crowther, M [1 ]
Cook, D [1 ]
Guyatt, G [1 ]
机构
[1] Univ Buffalo, Dept Med, Div Gen Internal Med, Buffalo, NY 14226 USA
关键词
D O I
10.1378/chest.126.3_suppl.174S
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
This article describes the methodology for the Seventh American College of Chest Physicians (ACCP) Conference on Antithrombotic, and Thrombolytic Therapy: Evidence-Based Guidelines. Guideline authors began by specifying the population, the intervention and alternative, and the outcomes for each clinical question, and defined the criteria for eligible articles, including methodological criteria, for each recommendation. Librarians, in collaboration with guideline authors and methodologists, conducted systematic searches for evidence. Guideline authors systematically evaluated the evidence, considered the full range of benefits, risks, inconvenience, and costs associated with alternative management strategies, considered patients' underlying values and preferences, and made recommendations accordingly. To increase the likelihood that the recommendations adequately represent patient values and preferences, the development process included a review of recommendations by research methodologists, practicing generalists, and specialists. Chapters are organized so that evidence is clearly linked to the relevant recommendations, and that recommendations particularly sensitive to underlying values and preferences are explicitly identified. Authors paid careful attention to the strength of the underlying evidence and to the balance between risks and benefits, which are both reflected in the grades of recommendations. Thus, improvements to the process of making recommendations for the ACCP guidelines include the explicit definition of questions, transparent eligibility criteria for including studies, and the specification of values and preferences underlying recommendations where they are particularly relevant. In combination with our previous practice of grading recommendations according to their strength, and the methodological quality of the supporting studies, these innovations establish our guidelines as, by and large, evidence based.
引用
收藏
页码:174S / 178S
页数:5
相关论文
共 50 条
  • [41] Perioperative Management of Antithrombotic Therapy Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines
    Douketis, James D.
    Spyropoulos, Alex C.
    Spencer, Frederick A.
    Mayr, Michael
    Jaffer, Amir K.
    Eckman, Mark H.
    Dunn, Andrew S.
    Kunz, Regina
    CHEST, 2012, 141 (02) : E326S - E350S
  • [42] Antithrombotic Therapy in Neonates and Children Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    Monagle, Paul
    Chan, Anthony K. C.
    Goldenberg, Neil A.
    Ichord, Rebecca N.
    Journeycake, Janna M.
    Nowak-Goettl, Ulrike
    Vesely, Sara K.
    CHEST, 2012, 141 (02) : E737S - E801S
  • [43] Antithrombotic Therapy for Atrial Fibrillation Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    You, John J.
    Singer, Daniel E.
    Howard, Patricia A.
    Lane, Deirdre A.
    Eckman, Mark H.
    Fang, Margaret C.
    Hylek, Elaine M.
    Schulman, Sam
    Go, Alan S.
    Hughes, Michael
    Spencer, Frederick A.
    Manning, Warren J.
    Halperin, Jonathan L.
    Lip, Gregory Y. H.
    CHEST, 2012, 141 (02) : E531S - E575S
  • [44] Meeting Highlights: American College of Chest Physicians Conference in Austin, Texas
    不详
    AMERICAN JOURNAL OF MANAGED CARE, 2014, 1 : SP54 - SP57
  • [45] Antithrombotic Therapy in Arterial Thrombosis and Thromboembolism in COVID-19 An American College of Chest Physicians Expert Panel Report
    Potpara, Tatjana
    Angiolillo, Dominick J.
    Bikdeli, Behnood
    Capodanno, Davide
    Cole, Oana
    Yataco, Angel Coz
    Dan, Gheorghe-Andrei
    Harrison, Stephanie
    Iaccarino, Jonathan M.
    Moores, Lisa K.
    Ntaios, George
    Lip, Gregory Y. H.
    CHEST, 2023, 164 (06) : 1531 - 1550
  • [46] New Antithrombotic Drugs Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    Weitz, Jeffrey I.
    Eikelboom, John W.
    Samama, Meyer Michel
    CHEST, 2012, 141 (02) : E120S - E151S
  • [47] VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    Bates, Shannon M.
    Greer, Ian A.
    Middeldorp, Saskia
    Veenstra, David L.
    Prabulos, Anne-Marie
    Vandvik, Per Olav
    CHEST, 2012, 141 (02) : E691S - E736S
  • [48] Antithrombotic Therapy in Peripheral Artery Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    Alonso-Coello, Pablo
    Bellmunt, Sergi
    McGorrian, Catherine
    Anand, Sonia S.
    Guzman, Randolph
    Criqui, Michael H.
    Akl, Elie A.
    Vandvik, Per Olav
    Lansberg, Maarten G.
    Guyatt, Gordon H.
    Spencer, Frederick A.
    CHEST, 2012, 141 (02) : E669S - E690S
  • [49] THROMBOLYTIC THERAPY IN THROMBOSIS - A NATIONAL-INSTITUTES-OF-HEALTH CONSENSUS DEVELOPMENT CONFERENCE
    SHERRY, S
    BELL, WR
    DUCKERT, FH
    FLETCHER, AP
    GUREWICH, V
    LONG, DM
    MARDER, VJ
    ROBERTS, H
    SALZMAN, EW
    SASAHARA, A
    VERSTRAETE, M
    ANNALS OF INTERNAL MEDICINE, 1980, 93 (01) : 141 - 144